MLICM
ARIA

Metropolitan Life Insurance Company (MetLife)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-124,544
Closed -$1.55M – 2585
2016
Q4 		$1.55M Sell
124,544
-2,395
-2% -$28.8K 0.01% 1062
2016
Q3 		$1.74M Sell
126,939
-2,703
-2% -$27.1K 0.01% 1005
2016
Q2 		$958K Buy
129,642
+9,738
+8% +$73.1K 0.01% 1284
2016
Q1 		$766K Hold
119,904
– – 0.01% 1312
2015
Q4 		$749K Hold
119,904
– – 0.01% 1350
2015
Q3 		$700K Buy
119,904
+1,932
+2% +$14.9K 0.01% 1402
2015
Q2 		$976K Sell
117,972
-10,006
-8% -$88.5K 0.01% 1302
2015
Q1 		$1.05M Sell
127,978
-272
-0.2% -$2.01K 0.01% 1170
2014
Q4 		$881K Hold
128,250
– – 0.01% 1408
2014
Q3 		$693K Hold
128,250
– – 0.01% 1502
2014
Q2 		$817K Buy
128,250
+115,545
+909% +$795K 0.01% 1492
2014
Q1 		$102K Hold
12,705
– – ﹤0.01% 2636
2013
Q4 		$87K Hold
12,705
– – ﹤0.01% 2663
2013
Q3 		$234K Sell
12,705
-170
-1% -$3.3K ﹤0.01% 2299
2013
Q2 		$225K Buy
+12,875
New +$228K ﹤0.01% 2268

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ARIA Position: Q1 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 124,544 shares — an estimated $1.55M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $1.74M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 124,544 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.55M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ariad Pharmaceuticals Inc position peaked at $1.74M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2017, filed 15 May 2017.